Amalgamated Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52K | Hold |
3,723
| – | – | ﹤0.01% | 1818 |
|
|
2025
Q1 | $58K | Buy |
3,723
+1,053
| +39% | +$16.4K | ﹤0.01% | 1769 |
|
|
2024
Q4 | $37K | Hold |
2,670
| – | – | ﹤0.01% | 1909 |
|
|
2024
Q3 | $25K | Hold |
2,670
| – | – | ﹤0.01% | 2038 |
|
|
2024
Q2 | $25K | Hold |
2,670
| – | – | ﹤0.01% | 2039 |
|
|
2024
Q1 | $26K | Sell |
2,670
-8,408
| -76% | -$81.9K | ﹤0.01% | 2034 |
|
|
2023
Q4 | $36K | Buy |
11,078
+3,639
| +49% | +$11.8K | ﹤0.01% | 2386 |
|
|
2023
Q3 | $40K | Hold |
7,439
| – | – | ﹤0.01% | 2339 |
|
|
2023
Q2 | $71K | Buy |
7,439
+1,624
| +28% | +$15.5K | ﹤0.01% | 2184 |
|
|
2023
Q1 | $64K | Sell |
5,815
-797
| -12% | -$8.77K | ﹤0.01% | 2202 |
|
|
2022
Q4 | $98K | Hold |
6,612
| – | – | ﹤0.01% | 2142 |
|
|
2022
Q3 | $126K | Buy |
6,612
+1,079
| +20% | +$20.6K | ﹤0.01% | 2042 |
|
|
2022
Q2 | $118K | Buy |
5,533
+2,074
| +60% | +$44.2K | ﹤0.01% | 2097 |
|
|
2022
Q1 | $67K | Buy |
+3,459
| New | +$67K | ﹤0.01% | 2331 |
|